Weil Advised Advent International Corporation in its Stake Acquisition of RxBenefits, Inc.

Weil advised Advent International Corporation in its acquisition of an approximately 50% stake in RxBenefits, Inc., the employee benefits industry’s first and only technology-enabled pharmacy benefits optimizer, from Great Hill Equity Partners, which retained a significant equity stake. The transaction values RxBenefits, Inc. at approximately $1.1 billion.

The Weil team that advised Advent International was led by Private Equity partner Marilyn French Shaw and included Private Equity partner Ramona Nee and Private Equity associates Ololade Oladapo, Jason OttomanoMolly MacDougall and Ryan Strassman. The team also included Tax partner Noah Beck; Tax associate Jacob Gerrit Meninga; Private Equity Executive Compensation & Benefits Head Michael Nissan; Executive Compensation & Benefits partner Amy Rubin; Executive Compensation & Benefits associates Radhika Tahiliani and Tamara Roth; Technology & IP Transactions partner Jeffrey Osterman; Privacy & Cybersecurity Co-Head Randi Singer; Technology & IP Transactions/Privacy associates Robert BrownLuis Gonzalez and Maryann Thompson; Banking & Finance partners Allison Liff and Benton Lewis; Banking & Finance associate Vaishali Mahna; Environmental Head Annemargaret Connolly; Regulatory Transactions counsel John O’Loughlin; Regulatory Transactions associate Ariel Fliman; Antitrust partner Vadim Brusser; Employment Litigation partner Nicholas Pappas; and Employment Litigation associate Thomas McCarthy.